Switzerland's health authority has been granted approval to establish the first legal adult-use cannabis dispensaries in Europe amid a pilot project.
Germany-based cannabis company Sanity Group and the Swiss Institute for Addiction and Health Research (ISGF) obtained this week the final approval from the Federal Office of Public Health (BAG) to launch a cannabis pilot study in Basel-Landschaft (Baselland). This approval comes after receiving the green light from the Ethics Committee Northwest and Central Switzerland last year.
The study, known as the "Grashaus Projects," is scheduled to start later this year. Its primary goal is to gain a deeper understanding of the consequences of regulated cannabis availability. The knowledge gained from this study will play a pivotal role in shaping potential cannabis regulations in Switzerland.
Notably, Sanity Group is the only non-Swiss company participating in the Swiss pilot projects, which will start the distribution process by opening a store in Allschwil, with plans for another store in Liestal to follow.
Read more at forbes.com
